Stock UniverseDerived research view · source repositories remain read-only

Caris Life Sciences, Inc. (CAI)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.86
Global Rank
423
Market Cap
5.69B
Latest Close
16.49
RS Composite
-29.61% · G#3013

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-13.80%
3M
-11.30%
6M
-39.46%
1Y
-41.11%
3Y
-41.11%
5Y
-41.11%
10Y
-41.11%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.68M · 30-day average: 2.90M · Max drawdown over stored range: -62.98%

Research Snapshot

Relative Strength vs SPX

RS Composite-29.61%
20D RS-17.52%
60D RS-20.41%
120D RS-44.86%
Global RS Rank3013 · 10.19% percentile
Qualified+ RS Rank1159 · 7.87% percentile
Group ScopeQualified+
Primary RS Rank365 · 20.31% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank44 / 701
Primary Percentile93.87
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-08907.29Mn/a108.35M33.98M0.1591.98M30.68M61.30M232Mn/a11.94%3.75%10.14%6.76%822.22M381.40M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$0.15112.6x$3.914.2x$0.2662.4x$0.4041.6x

Shares Diluted: 232M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue258.485306.128412.26812.033
Revenue Growth (YoY)3000%18.432%34.669%96.971%
Gross Profit80.02291.258180.429539.168
Operating Income-315.756-319.551-257.12245.113
Free Cash Flow-327.961-298.419-253.64366.895
Free Cash Flow Per Share-9.829-8.54-7.1460.4
EPS (Diluted) GAAP-11.983186-13.23673-10.656077-3.22
EPS Growth
EPS Non-GAAP
Gross Margin30.958%29.81%43.766%66.397%
Operating Margin-122.156%-104.385%-62.369%5.556%
Profit Margin-154.681%-151.089%-91.752%-66.248%
Free Cash Flow Margin-126.878%-97.482%-61.525%8.238%
Shares Outstanding (Diluted)33.365734.942735.4968167.2056
Shares Change (YoY)3000%4.726%1.586%371.044%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-08216.17Mn/a5.28M2.44%-510.00K-0.24%0.00282.56M822.22M381.40Mprocessed
2025 Q42026-03-03292.89Mn/a88.41M30.19%81.96M27.98%0.29283.48M798.57M378.82Mprocessed
2025 Q32025-11-05216.83Mn/a32.64M15.05%24.32M11.22%0.08297.21M755.49M376.30Mprocessed
2025 Q22025-08-12181.40Mn/a-17.99M-9.92%-71.79M-39.58%-7.9764.92M721.18M373.61Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.